{"id":"W2070487917","doi":"10.3109/10428194.2015.1022770","title":"Management of adverse events associated with idelalisib treatment: expert panel opinion","year":2015,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":true,"ca_institutions":"Gilead Sciences (Canada)","funders":"Gilead Sciences","keywords":"Idelalisib; Medicine; Adverse effect; Internal medicine; Diarrhea; Intensive care medicine; Ibrutinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009679971,0.002398019,0.006387891,0.0009933211,0.0003054323,0.00004630254,0.0009583418,0.001812875,0.0001089905],"category_scores_gemma":[0.0001258164,0.001759681,0.001348235,0.001866215,0.000746071,0.0003754091,0.0006755177,0.0003302151,0.0001848982],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2022216,"about_ca_system_score_gemma":0.05651086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002856337,"about_ca_topic_score_gemma":0.00004105363,"domain_scores_codex":[0.9899365,0.00059492,0.002508818,0.002376053,0.002585918,0.001997744],"domain_scores_gemma":[0.9932269,0.0005730712,0.001614646,0.002539071,0.0005708447,0.001475458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001132478,0.0008034048,0.00004409983,0.01709248,0.006317613,0.00336833,0.0006428214,0.00001408533,0.000001659329,0.0002947546,0.001737145,0.9685512],"study_design_scores_gemma":[0.08059497,0.002098282,0.0003141187,0.05741021,0.005439396,0.004573909,0.0006116335,0.001026831,0.00003331022,0.00006613946,0.8459325,0.001898677],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01091514,0.9755473,0.0000254007,0.00002047829,0.0005868771,0.004494747,0.0003527202,0.0003710089,0.007686339],"genre_scores_gemma":[0.003213077,0.9844794,0.0006217107,0.000110165,0.0004814593,0.001039611,0.002423804,0.0005357206,0.007095058],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9666525,"threshold_uncertainty_score":0.999483,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07781209335968814,"score_gpt":0.3511248248391235,"score_spread":0.2733127314794354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}